Equity Overview
Price & Market Data
Price: $0.29
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $8,247,563
Daily Volume: 0
Performance Metrics
1 Week: -11.57%
1 Month: -13.49%
3 Months: 37.41%
6 Months: -60.97%
1 Year: -83.25%
YTD: -68.15%
Company Details
Employees: 57
Sector: Health technology
Industry: Medical specialties
Country:
Details
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.